HOME >> MEDICINE >> NEWS
U of MN earns $7.9 million NIH grant to expand neuroscience research

The University of Minnesota's Center for Magnetic Resonance Research (CMRR) was one of four institutions in the country to receive a NIH Blueprint Grant for Neuroscience Research.

The $7.9 million award (approximately $1.5 million each year for five years) will be used to open up the CMRR's imaging technology to more neuroscience researchers across departments in the University. CMRR's application received the highest score of the 40 institutions that applied for the grant.

"This grant is a result of all of our work on brain sciences at the CMRR," said Kamil Ugurbil, Ph.D., director of CMRR and professor of radiology, neuroscience and medicine at the University of Minnesota Medical School. "Now we will be able to expand it quite a bit by creating an environment that allows our technology to be used by the larger neuroscience community."

CMRR is an interdisciplinary research laboratory that houses state-of-the-art magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) equipment for use in biomedical research. The central aim of the research conducted in CMRR is to develop non-invasive MR methods and technology for the acquisition of functional, physiological, and biochemical information in intact biological systems, and to use this capability to probe biological processes in health and disease.

Development of functional brain imaging and imaging of Alzheimer's plaques are examples of first-time accomplishments that are credited to the unique high magnetic field MR research carried out in CMRR. CMRR's magnets are six times as strong as most MRI machines found in a typical clinical setting.

The NIH Blueprint for Neuroscience Research grants were developed as a partnership between 15 NIH institutes and centers to accelerate neuroscience research. As opposed to funding individual research projects, these grants encourage the creation of centralized infrastructures that will expand and facilitate neuroscience research by
'"/>

Contact: Sara E. Buss
buss@umn.edu
612-624-2449
University of Minnesota
17-Oct-2006


Page: 1 2

Related medicine news :

1. Tennessee researcher earns Komen grant to study depression and breast cancer
2. Northwestern Memorial earns magnet status for nursing excellence
3. Surgical critical care team at HUP earns Beacon Award for Critical Care Excellence
4. UK College of Public Health earns national accreditation
5. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
6. Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions
7. FPG receives $8 million for autism research
8. CIRM awards $3.79 million to Burnham Institute
9. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
10. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
11. Mayor of New York proposes preventing 100 million deaths from tobacco

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: earns million NIH grant expand neuroscience research

(Date:3/2/2015)... March 02, 2015 Over the last ... among leading vendors seeking to expand their geographic presence ... is expected to reach $6.2 billion by 2019 at ... America including the U.S. and Canada and a major ... However developing regions such as Asia-Pacific including China and ...
(Date:3/2/2015)... The minimally invasive surgical instruments ... of 6.1% to reach $14,133.0 million by 2019 ... such as advantages of minimally invasive surgeries over ... minimally invasive surgeries and increasing number of surgical ... global minimally invasive surgical instruments market. , For ...
(Date:3/2/2015)... 02, 2015 LegitScript, LLC, ... certification programs, including those for Internet pharmacy ... safety and classification, has launched a certification ... The new program, called iCareRx , ... regarding the identity of the owner/operator of ...
(Date:3/2/2015)... Atlantic Information Services, Inc. (AIS) is pleased to ... Plans: 2015 , the all-new 12th edition of the ... market, with enrollment data and contact information for health ... as a printed book containing the full directory and ... and charts, as well as an electronic version, AIS’s ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Regulatory ... focused on quality, regulatory and technical consulting, announces ... Chief Operating Officer. , Before joining RCA, ... leading R&D teams in all aspects of developing ... positions at Covidien (Medtronic), Regulatory Compliance Associates Inc., ...
Breaking Medicine News(10 mins):Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2Health News:LegitScript Launches Certification Program for Internet Eyeglass Sellers 2Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2
(Date:3/2/2015)... 2015  DURECT Corporation (Nasdaq: DRRX ... the successful completion of a Phase 1 clinical ... DUR-928 is an endogenous, small-molecule, new chemical entity ... diseases such as nonalcoholic fatty liver disease (NAFLD) ... injuries such as acute kidney injury (AKI).        ...
(Date:3/2/2015)... 2, 2015  Intrexon Corporation (NYSE: ... announced its fourth quarter and full year results ... Recent Developments: , Acquired ActoGeniX, a European ... in cellular therapeutics and other innovative products.  Its ... food-grade microbes ( Lactococcus lactis ) to generate ...
(Date:3/2/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) today reported financial ... 31, 2014. Financial highlights for the fourth quarter include revenues ... or $0.04 per share. This compares to revenues of $12.5 ... per share, for the fourth quarter of 2013. Financial highlights ... and a net loss of $68.4 million, or $0.56 per ...
Breaking Medicine Technology:DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 3Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 4Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 6Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 7Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 8Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 9Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 10Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 11Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 12Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 13Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 14Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 15Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 16Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 17Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 18Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 19Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 20Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 21Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 22Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 23Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 24Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 2Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 3Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 4Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 5Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 6Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 7Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 8Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 9
Cached News: